View Transcript
Episode Description
Exercise and CV outcomes, aldosterone modulation, AI for ECG reading, GLP-1 comparisons, end-of-life decisions, and another well-meaning policy that caused harm in veterans are discussed by John Mandrola, MD, in this week’s podcast.
This podcast is intended for healthcare professionals only.
To read a partial transcript or to comment, visit:
I Exercise and CV outcomes
II Aldosterone Modulation in Cardio-Kidney Disease
- Aldosterone and Aldosterone Modulation https://doi.org/10.1016/j.jacc.2025.06.012
- Randomized Aldactone Evaluation Study https://www.nejm.org/doi/full/10.1056/NEJM199909023411001
III AI vs MD ECG-Reading for Cath Lab Activation
- Accuracy of Cath Lab Activation Decisions https://doi.org/10.1016/j.ajem.2025.07.061
IV Tirzepatide vs Dulaglutide - SURPASS CVOT Study
- Eli Lilly Press Release https://investor.lilly.com/news-releases/news-release-details/lillys-mounjaro-tirzepatide-gipglp-1-dual-agonist-demonstrated
- REWIND Study 10.1016/S0140-6736(19)31149-3 External Link
V End-of-Life Decisions
Doctors’ Own End-of-Life Choices Defy Common Medical Practice
- Physicians’ Preferences for Their Own End of Life https://jme.bmj.com/content/early/2025/06/05/jme-2024-110192
- How US Doctors Die: A Cohort Study https://agsjournals.onlinelibrary.wiley.com/doi/full/10.1111/jgs.14112
VI Well-Meaning Policies That Make Sense
- The Mission Act and Cardiovascular Procedures https://jamanetwork.com/journals/jama/fullarticle/2837067
You may also like:
The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington
Questions or feedback, please contact news@medscape.net